Genomic Characterization of Carbapenem-Resistant Acinetobacter baumannii (CRAB) in Mechanically Ventilated COVID-19 Patients and Impact of Infection Control Measures on Reducing CRAB Circulation during the Second Wave of the SARS-CoV-2 Pandemic in Milan, Italy
- PMID: 36976013
- PMCID: PMC10100775
- DOI: 10.1128/spectrum.00209-23
Genomic Characterization of Carbapenem-Resistant Acinetobacter baumannii (CRAB) in Mechanically Ventilated COVID-19 Patients and Impact of Infection Control Measures on Reducing CRAB Circulation during the Second Wave of the SARS-CoV-2 Pandemic in Milan, Italy
Abstract
COVID-19 has significantly affected hospital infection prevention and control (IPC) practices, especially in intensive care units (ICUs). This frequently caused dissemination of multidrug-resistant organisms (MDROs), including carbapenem-resistant Acinetobacter baumannii (CRAB). Here, we report the management of a CRAB outbreak in a large ICU COVID-19 hub Hospital in Italy, together with retrospective genotypic analysis by whole-genome sequencing (WGS). Bacterial strains obtained from severe COVID-19 mechanically ventilated patients diagnosed with CRAB infection or colonization between October 2020 and May 2021 were analyzed by WGS to assess antimicrobial resistance and virulence genes, along with mobile genetic elements. Phylogenetic analysis in combination with epidemiological data was used to identify putative transmission chains. CRAB infections and colonization were diagnosed in 14/40 (35%) and 26/40 (65%) cases, respectively, with isolation within 48 h from admission in 7 cases (17.5%). All CRAB strains belonged to Pasteur sequence type 2 (ST2) and 5 different Oxford STs and presented blaOXA-23 gene-carrying Tn2006 transposons. Phylogenetic analysis revealed the existence of four transmission chains inside and among ICUs, circulating mainly between November and January 2021. A tailored IPC strategy was composed of a 5-point bundle, including ICU modules' temporary conversion to CRAB-ICUs and dynamic reopening, with limited impact on ICU admission rate. After its implementation, no CRAB transmission chains were detected. Our study underlies the potentiality of integrating classical epidemiological studies with genomic investigation to identify transmission routes during outbreaks, which could represent a valuable tool to ensure IPC strategies and prevent the spread of MDROs. IMPORTANCE Infection prevention and control (IPC) practices are of paramount importance for preventing the spread of multidrug-resistant organisms (MDROs) in hospitals, especially in the intensive care unit (ICU). Whole-genome sequencing (WGS) is seen as a promising tool for IPC, but its employment is currently still limited. COVID-19 pandemics have posed dramatic challenges in IPC practices, causing worldwide several outbreaks of MDROs, including carbapenem-resistant Acinetobacter baumannii (CRAB). We present the management of a CRAB outbreak in a large ICU COVID-19 hub hospital in Italy using a tailored IPC strategy that allowed us to contain CRAB transmission while preventing ICU closure during a critical pandemic period. The analysis of clinical and epidemiological data coupled with retrospective genotypic analysis by WGS identified different putative transmission chains and confirmed the effectiveness of the IPC strategy implemented. This could be a promising approach for future IPC strategies.
Keywords: Acinetobacter baumannii CRAB; genomic surveillance; infection prevention and control (IPC); intensive care unit (ICU); phylogenetic analysis; whole-genome sequencing (WGS).
Conflict of interest statement
The authors declare a conflict of interest. Giacomo Grasselli reported: - payment for lectures from Pfizer, MSD, Mundipharma - unrestricted research grants from Pfizer and MSD - advisory board participation: Glaxo Smith Klein. Claudia Alteri acknowledges fees for lectures from Pfizer.
Figures



Similar articles
-
Investigation of an outbreak of carbapenem resistant Acinetobacter baumannii in an intensive care unit during the COVID-19 epidemic.Antimicrob Resist Infect Control. 2025 Apr 12;14(1):30. doi: 10.1186/s13756-025-01547-0. Antimicrob Resist Infect Control. 2025. PMID: 40221801 Free PMC article.
-
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit.Antimicrob Resist Infect Control. 2021 Aug 19;10(1):123. doi: 10.1186/s13756-021-00990-z. Antimicrob Resist Infect Control. 2021. PMID: 34412693 Free PMC article.
-
Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.Microb Pathog. 2019 Mar;128:75-81. doi: 10.1016/j.micpath.2018.12.023. Epub 2018 Dec 15. Microb Pathog. 2019. PMID: 30562602
-
Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals?Antibiotics (Basel). 2022 Jul 28;11(8):1015. doi: 10.3390/antibiotics11081015. Antibiotics (Basel). 2022. PMID: 36009885 Free PMC article. Review.
-
Carbapenem-resistant Acinetobacter baumannii: A challenge in the intensive care unit.Front Microbiol. 2022 Nov 10;13:1045206. doi: 10.3389/fmicb.2022.1045206. eCollection 2022. Front Microbiol. 2022. PMID: 36439795 Free PMC article. Review.
Cited by
-
Incidence, microbiological and immunological characteristics of ventilator-associated pneumonia assessed by bronchoalveolar lavage and endotracheal aspirate in a prospective cohort of COVID-19 patients: CoV-AP study.Crit Care. 2023 Sep 26;27(1):369. doi: 10.1186/s13054-023-04658-5. Crit Care. 2023. PMID: 37749631 Free PMC article.
-
Integrating Genomic Data into Public Health Surveillance for Multidrug-Resistant Organisms, Washington, USA.Emerg Infect Dis. 2025 May;31(13):25-34. doi: 10.3201/eid3113.241227. Emerg Infect Dis. 2025. PMID: 40359067 Free PMC article.
-
Understanding the burden of antibiotic resistance: a decade of carbapenem-resistant Gram-negative bacterial infections in Italian intensive care units.Front Microbiol. 2024 Jun 5;15:1405390. doi: 10.3389/fmicb.2024.1405390. eCollection 2024. Front Microbiol. 2024. PMID: 38903794 Free PMC article.
-
Transmission cluster of cefiderocol-non-susceptible carbapenem-resistant Acinetobacter baumannii in cefiderocol-naïve individuals.Ann Clin Microbiol Antimicrob. 2024 Nov 29;23(1):104. doi: 10.1186/s12941-024-00763-7. Ann Clin Microbiol Antimicrob. 2024. PMID: 39614286 Free PMC article.
-
Molecular Typing and Resistance Profile of Acinetobacter baumannii Isolates during the COVID-19 Pandemic: Findings from the "EPIRADIOCLINF" Project.Antibiotics (Basel). 2023 Oct 19;12(10):1551. doi: 10.3390/antibiotics12101551. Antibiotics (Basel). 2023. PMID: 37887252 Free PMC article.
References
-
- Vincent J-L, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, Finfer S, Pelosi P, Brazzi L, Aditianingsih D, Timsit J-F, Du B, Wittebole X, Máca J, Kannan S, Gorordo-Delsol LA, De Waele JJ, Mehta Y, Bonten MJM, Khanna AK, Kollef M, Human M, Angus DC, EPIC III Investigators . 2020. Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA 323:1478–1487. doi:10.1001/jama.2020.2717. - DOI - PMC - PubMed
-
- Martín-Aspas A, Guerrero-Sánchez FM, García-Colchero F, Rodríguez-Roca S, Girón-González JA. 2018. Differential characteristics of Acinetobacter baumannii colonization and infection: risk factors, clinical picture, and mortality. Infect Drug Resist 11:861–872. doi:10.2147/IDR.S163944. - DOI - PMC - PubMed
-
- Garnacho-Montero J, Gutiérrez-Pizarraya A, Díaz-Martín A, Cisneros-Herreros JM, Cano ME, Gato E, Ruiz de Alegría C, Fernández-Cuenca F, Vila J, Martínez-Martínez L, Tomás-Carmona MDM, Pascual Á, Bou G, Pachón-Diaz J, Rodríguez-Baño J. 2016. Acinetobacter baumannii in critically ill patients: molecular epidemiology, clinical features and predictors of mortality. Enferm Infecc Microbiol Clin 34:551–558. doi:10.1016/j.eimc.2015.11.018. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous